Assembly Biosciences, Inc.
ASMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426800
No open-market purchases or sales by Assembly Biosciences, Inc. insiders were filed in the last 90 days; 92 institutions reported holding it in 13F filings for Q2 2026, worth $514.8M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Assembly Biosciences, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 35 | 37 | +2 |
| Shares | 3.19M | 3.18M | −10.1K (−0.3%) |
| Value | $50.3M | $30.4M | −$19.9M (−39.6%) |
New holders (6)
Institutions that held Assembly Biosciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 18,982 | $181.5K | 0.00% |
| Citadel Advisors LLC | 12,258 | $117.2K | 0.00% |
| American Century Companies Inc | 11,799 | $112.8K | 0.00% |
| Wells Fargo & Company | 145 | $1.39K | 0.00% |
| Ameriflex Group, Inc. | 83 | $793 | 0.00% |
| Avion Wealth | 33 | $0 | 0.00% |
Sold out (4)
Institutions that held Assembly Biosciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Peapod Lane Capital LLC | 62,970 | $993.7K |
| Marquette Asset Management, LLC | 9,016 | $142.3K |
| GWM Advisors LLC | 846 | $13.3K |
| Advisor Group Holdings, Inc. | 187 | $2.95K |